Anti-HBs levels in children under the age of two years born to HBV carrier mothers after immunoprophylaxis: a multicenter cross-sectional study

[1]  Jue Liu,et al.  Eliminating mother-to-child transmission of HBV: progress and challenges in China , 2020, Frontiers of Medicine.

[2]  A. Horban,et al.  State of viral hepatitis care in 16 countries of Central and Eastern European Region. , 2019, Central European journal of public health.

[3]  V. Svicher,et al.  New Markers in Monitoring the Reactivation of Hepatitis B Virus Infection in Immunocompromised Hosts , 2019, Viruses.

[4]  Q. Wang,et al.  Outcomes of the national programme on prevention of mother-to-child transmission of hepatitis B virus in China, 2016–2017 , 2019, Infectious Diseases of Poverty.

[5]  H. Pouretemad,et al.  Measurement of serum hepatitis B surface antibody levels in Iranian autistic children and evaluation of immunological memory after booster dose injection in comparison with controls , 2019, Journal of medical virology.

[6]  T. Lao,et al.  Prevention of perinatal hepatitis B virus transmission , 2019, Archives of Gynecology and Obstetrics.

[7]  Y. Horsmans,et al.  Immunisation after hepatitis B polyvalent vaccination among children in South Kivu Province, Democratic Republic of the Congo. , 2019, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[8]  O. Nyan,et al.  Hepatitis B virus sero-prevalence amongst pregnant women in the Gambia , 2019, BMC Infectious Diseases.

[9]  R. Tohme,et al.  Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus — Western Pacific Region, 2005–2017 , 2019, MMWR. Morbidity and mortality weekly report.

[10]  Jue Liu,et al.  Countdown to 2030: eliminating hepatitis B disease, China , 2019, Bulletin of the World Health Organization.

[11]  C. Montesano,et al.  Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns , 2018, Journal of public health in Africa.

[12]  Yu Hu,et al.  Hepatitis B Vaccination among 1999–2017 Birth Cohorts in Zhejiang Province: The Determinants Associated with Infant Coverage , 2018, International journal of environmental research and public health.

[13]  Shengli Bi,et al.  Investigation of the risk factors associated with the failure of hepatitis B vaccination of neonates in Yunnan province, China. , 2018, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[14]  Hong‐Lin Chen,et al.  Maternal viral load and hepatitis B virus mother‐to‐child transmission risk: A systematic review and meta‐analysis , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

[15]  Y. Hutin,et al.  Preventing hepatitis B virus infection: milestones and targets , 2018, Bulletin of the World Health Organization.

[16]  C. Y. Lim,et al.  Hepatitis B virus infection among children of hepatitis B surface antigen positive mothers in a Malaysian hospital. , 2018, The Medical journal of Malaysia.

[17]  S. Alavian,et al.  Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. , 2018, The lancet. Gastroenterology & hepatology.

[18]  Yang Ding,et al.  Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China , 2018, International journal of medical sciences.

[19]  Bette C Liu,et al.  Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis , 2018, Bulletin of the World Health Organization.

[20]  Yiyin Wang,et al.  Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses. , 2018, Vaccine.

[21]  A. Huang,et al.  Changes and analysis of anti‐HBs titres after primary immunization in 1‐ to 16‐year‐old Chinese children: A hospital‐based study , 2018, Journal of viral hepatitis.

[22]  F. Cui,et al.  How to control highly endemic hepatitis B in Asia , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[23]  Publisher's Note , 2018, Anaesthesia.

[24]  S. Nagashima,et al.  Occult hepatitis B virus infection in immunized children born to carrier mothers , 2017, Pediatrics international : official journal of the Japan Pediatric Society.

[25]  S. Xie,et al.  Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014. , 2017, Vaccine.

[26]  Hui-hui Zheng,et al.  Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China. , 2017, Vaccine.

[27]  L. Madsen,et al.  Vertical transmission of hepatitis B virus during pregnancy and delivery in Denmark , 2017, Scandinavian journal of gastroenterology.

[28]  Shanshan Chen,et al.  Minimization of hepatitis B infection among children in Jiangsu, China, 12years after integration of hepatitis B vaccine into the expanded program on immunization. , 2016, Vaccine.

[29]  A. Tita,et al.  Hepatitis B in Pregnancy Screening, Treatment, and Prevention of Vertical Transmission , 2016 .

[30]  Xing Wu,et al.  Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure , 2016, Medicine.

[31]  A. Tita,et al.  #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. , 2016, American journal of obstetrics and gynecology.

[32]  Shumei Lin,et al.  Relationship between the mechanism of hepatitis B virus father–infant transmission and pregnancy outcome , 2016, Archives of Gynecology and Obstetrics.

[33]  C. Thio,et al.  Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy. , 2015, The Lancet. Infectious diseases.

[34]  W. Gerlich,et al.  Age-dependent decrease of anti-HBs titers and effect of booster doses using 2 different vaccines in Palestinian children vaccinated in early childhood , 2015, Human vaccines & immunotherapeutics.

[35]  Zhenglun Liang,et al.  Strategy vaccination against Hepatitis B in China , 2015, Human vaccines & immunotherapeutics.

[36]  S. Vermund,et al.  Integrated prevention of mother-to-child transmission for human immunodeficiency virus, syphilis and hepatitis B virus in China , 2014, Bulletin of the World Health Organization.

[37]  Aifen Zhou,et al.  Immunoprophylaxis Failure Against Vertical Transmission of Hepatitis B Virus in the Chinese Population: A Hospital-based Study and a Meta-analysis , 2014, The Pediatric infectious disease journal.

[38]  P. Ye,et al.  Breast feeding and immunoprophylaxis efficacy of mother-to-child transmission of hepatitis B virus , 2014, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[39]  Weili Yan,et al.  Genetic effects have a dominant role on poor responses to infant vaccination to hepatitis B virus , 2013, Journal of Human Genetics.

[40]  Lin Qing.  A CROSS-SECTIONAL INVESTIGATION ON THE STATUS OF HB VACCINE BEING BROUGHT INTO THE EXPANDED PROGRAM ON IMMUNIZATION , 2008 .